Resultados da pesquisa - brain tumor ((stem create) OR (stem treated))*

Pesquisas alternativas:
stem treated » stemi treated (Expandir a Pesquisa), steam treated (Expandir a Pesquisa), system treated (Expandir a Pesquisa)
brain tumor » brain tumors (Expandir a Pesquisa)
stem create » system create (Expandir a Pesquisa), stem chelate (Expandir a Pesquisa), system created (Expandir a Pesquisa)

141

Pharmacokinetics of thiotepa in high-dose regimens for autologous hematopoietic stem cell transplant in Japanese patients with pediatric tumors or adult lymphoma

Pharmacokinetics of thiotepa in high-dose regimens for autologous hematopoietic stem cell...

Por Kondo, Eisei, Ikeda, Takashi, Goto, Hiroaki, Nishikori, Momoko, Maeda, Naoko, Matsumoto, Kimikazu, Kitagawa, Hideo, Noda, Naoto, Sugimoto, Saori, Hara, Junichi
Publicado no Cancer Chemother Pharmacol (2019)

“... transplantation (HSCT) to treat solid tumors and hematological malignancies. This Phase 1 study was conducted...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

142

Clinical Trial of Human Fetal Brain-Derived Neural Stem/Progenitor Cell Transplantation in Patients with Traumatic Cervical Spinal Cord Injury

Clinical Trial of Human Fetal Brain-Derived Neural Stem/Progenitor Cell Transplantation in Patients with Traumatic Cervical Spinal Cord Injury

Por Shin, Ji Cheol, Kim, Keung Nyun, Yoo, Jeehyun, Kim, Il-Sun, Yun, Seokhwan, Lee, Hyejin, Jung, Kwangsoo, Hwang, Kyujin, Kim, Miri, Lee, Il-Shin, Shin, Jeong Eun, Park, Kook In
Publicado no Neural Plast (2015)

“... the safety and neurological effects of human neural stem/progenitor cells (hNSPCs) transplanted...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

143

Dual-modified cationic liposomes loaded with paclitaxel and survivin siRNA for targeted imaging and therapy of cancer stem cells in brain glioma

Dual-modified cationic liposomes loaded with paclitaxel and survivin siRNA for targeted imaging and therapy of cancer stem cells in brain glioma

Por Sun, Xiyang, Chen, Ying, Zhao, Hui, Qiao, Guanglei, Liu, Meiyang, Zhang, Chunlei, Cui, Daxiang, Ma, Lijun
Publicado no Drug Deliv (2018)

“... imaging and treating CD133(+) glioma stem cells after passing through the blood–brain barrier. After being...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

144

EXTH-75. IMAGING GLIOBLASTOMA STEM CELLS WITH 7-AMINO ACID-LENGTH TUMOR-HOMING PEPTIDE IDENTIFIED BY PHAGE DISPLAY BIOPANNING

EXTH-75. IMAGING GLIOBLASTOMA STEM CELLS WITH 7-AMINO ACID-LENGTH TUMOR-HOMING PEPTIDE IDENTIFIED BY PHAGE DISPLAY BIOPANNING

Por Kim, Jongmyung (John), Rich, Jeremy, Liu, James
Publicado no Neuro Oncol (2017)

“... and eradication of tumor cells with minimizing toxicity to normal tissues. Glioblastoma stem cells have earned a...”
Obter o texto integral
Obter o texto integral

Artigo

145

Transplantation of mesenchymal stem cells genetically engineered to overexpress interleukin-10 promotes alternative inflammatory response in rat model of traumatic brain injury

Transplantation of mesenchymal stem cells genetically engineered to overexpress interleukin-10...

Por Peruzzaro, S. T., Andrews, M. M. M., Al-Gharaibeh, A., Pupiec, O., Resk, M., Story, D., Maiti, P., Rossignol, J., Dunbar, G. L.
Publicado no J Neuroinflammation (2019)

“...BACKGROUND: Traumatic brain injury (TBI) is a major cause for long-term disability, yet...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

146

Magnetic resonance imaging is essential prior to spinal subarachnoid blockade for parturients with a history of brain tumor resection undergoing cesarean section

Magnetic resonance imaging is essential prior to spinal subarachnoid blockade for parturients with a history of brain tumor resection undergoing cesarean section

Por Ghaly, Ramsis F., Candido, Kenneth D., Chupatanakul, Lalida, Knezevic, Nebojsa Nick
Publicado em 2012

“...BACKGROUND: Primary brain tumors are usually treated by surgical removal with the goal of complete...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

147

OS06.2 Combination RNAi therapy against glioma stem cells via sustained lipopolymeric nanoparticle delivery delays tumor progression

OS06.2 Combination RNAi therapy against glioma stem cells via sustained lipopolymeric nanoparticle delivery delays tumor progression

Por Yu, D., Khan, O. F., Suvà, M. L., Panek, W. K., Wu, M., Han, Y., Ahmed, A. U., Balyasnikova, I. V., Anderson, D. G., Langer, R., Lesniak, M. S.
Publicado no Neuro Oncol (2017)

“... GSC targeting strategy when delivered directly to the brain tumor microenvironment. In vitro...”
Obter o texto integral
Obter o texto integral

Artigo

148

Antitumor Activities and Cellular Changes Induced by TrkB Inhibition in Medulloblastoma

Antitumor Activities and Cellular Changes Induced by TrkB Inhibition in Medulloblastoma

Por Amanda Thomaz, Amanda Thomaz, Kelly de Vargas Pinheiro, Kelly de Vargas Pinheiro, Bárbara Kunzler Souza, Bárbara Kunzler Souza, Lauro Gregianin, Lauro Gregianin, Lauro Gregianin, Algemir L. Brunetto, Algemir L. Brunetto, André T. Brunetto, André T. Brunetto, Caroline Brunetto de Farias, Caroline Brunetto de Farias, Mariane da Cunha Jaeger, Mariane da Cunha Jaeger, Vijay Ramaswamy, Vijay Ramaswamy, Carolina Nör, Carolina Nör, Michael D. Taylor, Michael D. Taylor, Michael D. Taylor, Michael D. Taylor, Michael D. Taylor, Rafael Roesler, Rafael Roesler
Publicado em 2019-06-01

Assuntos: “...brain tumor...”
Obter o texto integral

Artigo

149

Genetic selection of sox1GFP-expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation

Genetic selection of sox1GFP-expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation

Por Chung, S., Shin, B.-S., Hedlund, E., Pruszak, J., Ferree, A., Kang, Un Jung, Isacson, Ole, Kim, Kwang-Soo
Publicado em 2006

“... stem (ES) cells are a potential source of cells for transplantation therapy of various diseases...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

150

$Phase I Trial of Weekly MK-0752 in Children with Refractory Central Nervous System Malignancies: A Pediatric Brain Tumor Consortium Study$

Phase I Trial of Weekly MK-0752 in Children with Refractory Central Nervous System Malignancies: A Pediatric Brain Tumor Consortium Study

Por Hoffman, Lindsey M., Fouladi, Maryam, Olson, James, Daryani, Vinay M., Stewart, Clinton F., Wetmore, Cynthia, Kocak, Mehmet, Onar-Thomas, Arzu, Wagner, Lars, Gururangan, Sridharan, Packer, Roger J., Blaney, Susan M., Gajjar, Amar, Kun, Larry E., Boyett, James M., Gilbertson, Richard J.
Publicado no Childs Nerv Syst (2015)

“... types of pediatric brain tumors. A phase I trial of weekly MK-0752, an oral inhibitor of gamma-secretase...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

151

OS12.1 Editing of IDH1 R132H mutation in human induced pluripotent stem cells to investigate tumor genesis in glioma

OS12.1 Editing of IDH1 R132H mutation in human induced pluripotent stem cells to investigate tumor genesis in glioma

Por Köpp, A, Preussler, M, Richter, S, Heide, M, Marrone, L, Sterneckert, J, Schöler, A, Capper, D, Schröck, E, Klink, B
Publicado no Neuro Oncol (2019)

“.... Thus, we aim at creating human induced pluripotent stem cells (hiPSC) carrying the IDH1 R132H mutation...”
Obter o texto integral
Obter o texto integral

Artigo

152

P11.31 EB1-dependent survival of glioblastoma tumor-bearing mice after treatment with the novel checkpoint activator BAL101553 is associated with inhibition of cancer stem-like cell-mediated tumor angiogenesis and astrocytic differentiation

P11.31 EB1-dependent survival of glioblastoma tumor-bearing mice after treatment with the novel checkpoint activator BAL101553 is associated with inhibition of cancer stem-like cell-mediated tumor...

Por Berges, R, Tchoghandjian, A, Serge, A, Honore, S, Figarella-Branger, D, Bachmann, F, Lane, H, Braguer, D
Publicado no Neuro Oncol (2019)

“... as compared to EB1-downregulated tumors. This was associated with inhibition of stem cell properties...”
Obter o texto integral
Obter o texto integral

Artigo

153

SC-26 CD57 DEFINES A NOVEL MAKER OF GLIOBLASTOMA STEM CELLS THAT HAVE GREATER INVASIVE POTENTIAL THAN CD133+ TUMOR CELLS

SC-26 CD57 DEFINES A NOVEL MAKER OF GLIOBLASTOMA STEM CELLS THAT HAVE GREATER INVASIVE POTENTIAL THAN CD133+ TUMOR CELLS

Por Qi, Lin, Huang, Yulun, Kogiso, Mari, Mao, Hua, Lindsay, Holly, Baxter, Patricia, Su, Jack, Perlaky, Laszlo, Lau, Ching, Chintagumpala, Murali, Li, Xiao-Nan
Publicado no Neuro Oncol (2014)

“...Diffuse invasion into normal brain is one of the hallmark features that make GBM difficult to treat...”
Obter o texto integral
Obter o texto integral

Artigo

154

Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer

Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer

Por Connolly, Nina P., Stokum, Jesse A., Schneider, Craig S., Ozawa, Tatsuya, Xu, Su, Galisteo, Rebeca, Castellani, Rudolph J., Kim, Anthony J., Simard, J. Marc, Winkles, Jeffrey A., Holland, Eric C., Woodworth, Graeme F.
Publicado no PLoS One (2017)

“... of its smaller brain size that limited time allowed for tumor progression. Here we illustrate a method...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

155

DDIS-18. TARGETING DIPGs THROUGH SUPER-ACTIVATION OF STEROID RECEPTOR CO-ACTIVATOR: AN IN VIVO STUDY IN PATIENT-DERIVED INTRA-BRAIN STEM XENOGRAFT MOUSE MODELS

DDIS-18. TARGETING DIPGs THROUGH SUPER-ACTIVATION OF STEROID RECEPTOR CO-ACTIVATOR: AN IN VIVO STUDY IN PATIENT-DERIVED INTRA-BRAIN STEM XENOGRAFT MOUSE MODELS

Por Du, Yuchen, Qi, Lin, Kogiso, Mari, Braun, Frank, Zhang, Huiyuan, Lindsay, Holly, Zhao, Sibo, Injac, Sarah, O’Malley, Bert, Lonard, David M, Li, Xiao-Nan
Publicado no Neuro Oncol (2017)

“... of DIPG in the brain stems from biopsy or autopsied tumor tissues. Cell killing assay under MCB-613 (from...”
Obter o texto integral
Obter o texto integral

Artigo

156

O7.08 ONE-STOP SHOPPING IN BRAIN TUMOR IMAGING: INITIAL EXPERIENCE WITH PET/MR FOR SIMULTANEOUS EVALUATION OF TUMOR METABOLISM, STRUCTURE AND BLOOD VOLUME USING [18F]-FLUOR-ETHYL-THYROSINE PET AND DSC-MRI

O7.08 ONE-STOP SHOPPING IN BRAIN TUMOR IMAGING: INITIAL EXPERIENCE WITH PET/MR FOR SIMULTANEOUS...

Por Henriksen, O.M., Larsen, V.A., Muhic, A., Hansen, A.E., Larsson, H.B.W., Poulsen, H.S., Law, I.
Publicado em 2014

“... evaluations of patients with brain tumors. MRI blood volume (BV) imaging using dynamic susceptibility contrast...”
Obter o texto integral
Obter o texto integral

Artigo

157

Tumors of the central nervous system spinal tumors (part 1) /

Tumors of the central nervous system spinal tumors (part 1) /

Por Hayat, M. A.
Publicado em c201

“...Tumors of the central nervous system...”
Obter o texto integral

Livro

158

Honokiol Eliminates Glioma/Glioblastoma Stem Cell-Like Cells via JAK-STAT3 Signaling and Inhibits Tumor Progression by Targeting Epidermal Growth Factor Receptor

Honokiol Eliminates Glioma/Glioblastoma Stem Cell-Like Cells via JAK-STAT3 Signaling and Inhibits...

Por Fan, Yipu, Xue, Weikang, Schachner, Melitta, Zhao, Weijiang
Publicado no Cancers (Basel) (2018)

“...Malignant gliomas are the most aggressive forms of brain tumors; whose metastasis and recurrence...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

159

CSIG-22. A CD133-Akt-Wnt SIGNALING AXIS PROVIDES FUNCTIONAL INSIGHT INTO THE ROLE OF CD133 IN GLIOBLASTOMA BRAIN TUMOR-INITIATING CELLS

CSIG-22. A CD133-Akt-Wnt SIGNALING AXIS PROVIDES FUNCTIONAL INSIGHT INTO THE ROLE OF CD133 IN GLIOBLASTOMA BRAIN TUMOR-INITIATING CELLS

Por Manoranjan, Branavan, Venugopal, Chitra, Mahendram, Sujeivan, Subapanditha, Minomi, Savage, Neil, Qazi, Maleeha, Vora, Parvez, Moffat, Jason, Doble, Bradley, Singh, Sheila
Publicado no Neuro Oncol (2017)

“... as a marker of tumor-initiating cells in a number of human cancers associated with activated Wnt...”
Obter o texto integral
Obter o texto integral

Artigo

160

Stem Cells and Human Diseases

Stem Cells and Human Diseases

Por Srivastava, Rakesh K., Shankar, Sharmila.
Publicado em 2012

“... for treating and preventing cancers by targeting cancer stem cells or cancer initiating cells. An increased...”
Obter o texto integral

Livro

[1]
Anterior
3
4
5
6
7
8
9
10
11
12
13
Seguinte
[29]